182 related articles for article (PubMed ID: 29556024)
41. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
[TBL] [Abstract][Full Text] [Related]
42. SIL-TAL1 rearrangement is related with poor outcome: a study from a Chinese institution.
Wang D; Zhu G; Wang N; Zhou X; Yang Y; Zhou S; Xiong J; He J; Jiang L; Li C; Xu D; Huang L; Zhou J
PLoS One; 2013; 8(9):e73865. PubMed ID: 24040098
[TBL] [Abstract][Full Text] [Related]
43. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
[TBL] [Abstract][Full Text] [Related]
44. Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL.
Hannon MM; Lohan F; Erbilgin Y; Sayitoglu M; O'Hagan K; Mills K; Ozbek U; Keeshan K
Br J Haematol; 2012 Sep; 158(5):626-34. PubMed ID: 22775572
[TBL] [Abstract][Full Text] [Related]
45. Concurrent peripheral T-cell lymphoma and T-cell lymphoblastic leukemia/lymphoma with identical
Khanlari M; Wang W; Liu YC; Wang L; Rubnitz JE; Dixon S; Orr BA; Anelo OM; Cheng Z; Balagopal V; Klco JM
Haematologica; 2024 Mar; 109(3):994-999. PubMed ID: 37767572
[No Abstract] [Full Text] [Related]
46. Genetic variegation of clonal architecture and propagating cells in leukaemia.
Anderson K; Lutz C; van Delft FW; Bateman CM; Guo Y; Colman SM; Kempski H; Moorman AV; Titley I; Swansbury J; Kearney L; Enver T; Greaves M
Nature; 2011 Jan; 469(7330):356-61. PubMed ID: 21160474
[TBL] [Abstract][Full Text] [Related]
47. S1P-S1PR3-RAS promotes the progression of S1PR3
Zhu D; Jiang T; Ma D; Zhang H; Zhang J; Lv W; Gong M; Wang H; Liu Z; Su H; Zeng L; Liu S; Tang S; Yang B; Tshavuka FI; Fu G; Liu Z; Peng D; Liu H; Yan Z; Cao Z; Zhao H; He TC; Yu J; Shu Y; Zou L
Leukemia; 2023 Oct; 37(10):1982-1993. PubMed ID: 37591940
[TBL] [Abstract][Full Text] [Related]
48. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
[TBL] [Abstract][Full Text] [Related]
49. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
50. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Larson Gedman A; Chen Q; Kugel Desmoulin S; Ge Y; LaFiura K; Haska CL; Cherian C; Devidas M; Linda SB; Taub JW; Matherly LH
Leukemia; 2009 Aug; 23(8):1417-25. PubMed ID: 19340001
[TBL] [Abstract][Full Text] [Related]
51. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.
Quentmeier H; Schneider B; Röhrs S; Romani J; Zaborski M; Macleod RA; Drexler HG
J Hematol Oncol; 2009 Jan; 2():3. PubMed ID: 19166587
[TBL] [Abstract][Full Text] [Related]
52. PEST domain NOTCH mutations confer a poor relapse free survival in pediatric T-ALL: Data from a tertiary care centre in India.
Bhatia P; Totadri S; Singh M; Sharma P; Trehan A; Bansal D; Jain R; Varma N; Sachdeva MS; Patra N
Blood Cells Mol Dis; 2020 May; 82():102419. PubMed ID: 32179411
[TBL] [Abstract][Full Text] [Related]
53. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
Bandapalli OR; Zimmermann M; Kox C; Stanulla M; Schrappe M; Ludwig WD; Koehler R; Muckenthaler MU; Kulozik AE
Haematologica; 2013 Jun; 98(6):928-36. PubMed ID: 23349303
[TBL] [Abstract][Full Text] [Related]
54. [Clinical Characteristics and Treatment Efficacy of Children with SIL/TAL1 Positive T-Cell Acute Lymphoblastic Leukemia].
Liu X; Li WJ; Zhao XX; Gao C; Zhao W; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Cui L; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):681-6. PubMed ID: 27342490
[TBL] [Abstract][Full Text] [Related]
55. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
Curry JD; Smith MT
Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
[TBL] [Abstract][Full Text] [Related]
56. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
[TBL] [Abstract][Full Text] [Related]
57. Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
Jenkinson S; Kirkwood AA; Goulden N; Vora A; Linch DC; Gale RE
Leukemia; 2016 Jan; 30(1):39-47. PubMed ID: 26220040
[TBL] [Abstract][Full Text] [Related]
58. Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia.
La Starza R; Pierini V; Pierini T; Nofrini V; Matteucci C; Arniani S; Moretti M; Lema Fernandez AG; Pellanera F; Di Giacomo D; Storlazzi TC; Vitale A; Gorello P; Sammarelli G; Roti G; Basso G; Chiaretti S; Foà R; Schwab C; Harrison CJ; Van Vlierberghe P; Mecucci C
J Mol Diagn; 2020 May; 22(5):629-639. PubMed ID: 32142900
[TBL] [Abstract][Full Text] [Related]
59. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
60. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
